Acrivon Therapeutics, Inc. Financial Overview
Acrivon Therapeutics, Inc.'s market cap is currently $76.36M. The company's EPS TTM is $-0.47; its P/E ratio is -1.08; Acrivon Therapeutics, Inc. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
